CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Brown Glaucoma Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03469297
NCT03469297N/ACompleted
CompareCT.gov

Early Feasibility Study of the Brown Glaucoma Implant in Patients With No Light Perceived

MicroOptx·interventional·Posted Mar 19, 2018·Updated Dec 28, 2022

In Brief

A clinical study evaluating Brown Glaucoma Implant for Glaucoma. Completed, enrolled 8 participants across 3 sites.

Detailed Summary

This is a prospective, non-randomized, single-arm early feasibility study to assess the safety and feasibility of lowering intraocular pressure with the Brown Glaucoma Implant. A total of up to 10 subjects will be enrolled at three centers. Subjects will be followed for 24 months, with the primary assessments completed 6 months after implant.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 19, 2018
Enrollment StartMay 1, 2018
Primary CompletionMar 26, 2020
Study CompletionSep 20, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.3 years ago

Interventions

Brown Glaucoma Implantdevice

The Brown Glaucoma Implant (BGI) is an implantable device designed to lower intraocular pressure (IOP) in glaucoma patients by shunting aqueous humor from the anterior chamber of the eye to the surface of the eye. Because there are no physiologic sources of outflow resistance, the device can be engineered to target an IOP that is low enough to halt the progression to blindness in a patient suffering from glaucoma.